SOURCE: Equity News Circuit

Equity News Circuit

March 26, 2013 08:45 ET

Free Research Reports on CTIC, HZNP, LEDS and STXS Issued by the Bedford Report

Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY--(Marketwire - Mar 26, 2013) - The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Cell Therapeutics Inc. (NASDAQ: CTIC) shares fell 13.01 percent on volume of over 6 million shares traded Monday to close at $1.07 a share. The company reported a net loss of $115.3 million for the full year 2012, compared to a net loss of $121.1 million for the full year 2011.

Find out more about Cell Therapeutics including full access to the free equity report at: www.BedfordReport.com/CTIC

Horizon Pharma Inc. (NASDAQ: HZNP) shares spiked 14.29 percent on nearly five times the average daily volume Monday to close at $2.88 a share. The company reported gross and net sales for the full year 2012 were $23.0 million and $19.6 million, respectively, increases of 231% and 183% when compared to a year ago.

Find out more about Horizon Pharma including full access to the free equity report at: www.BedfordReport.com/HZNP

SemiLEDs Corporation (NASDAQ: LEDS) shares gained 14.29 percent on nearly three times the average daily volume Monday to close at $1.28 a share. LED manufacturers have surged in 2013 on the prospects of growth within lighting market. Greg Sebasky, CEO of Philips' North American Unit, expects the LED lighting market to grow by 40 percent in 2013.

Find out more about SemiLEDs including full access to the free equity report at: www.BedfordReport.com/LEDS

Stereotaxis Inc. (NASDAQ: STXS) shares surged 33.52 percent on volume of over 4 million shares traded Monday to close at $2.39 a share. The company announced it has received regulatory approval of its Niobe remote magnetic technology in Japan and has begun commercialization efforts.

Find out more about Stereotaxis including full access to the free equity report at: www.BedfordReport.com/STXS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information